B
Bioceres Crop Solutions Corp (BIOX)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NASDAQ
$0.20
-0.01 (-4.90%)
Market Cap: $13.40M
Last updated: Nov 17, 2026 at 10:59 AM ET
Bioceres Crop Solutions Corp (BIOX) Valuation Multiples
Bioceres Crop Solutions (BIOX) trades at 0.3x book value. Its P/B of 0.3x is below its 5-year median of 2.4x. Its forward P/E is 15.0x.
Current Multiples
Its enterprise value is 86.8x its EBITDA. Its free cash flow yield is 568.4%.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 15.0x |
| Price to book | 0.3x |
| EV/EBITDA | 86.8x |
| Price to FCF | 0.2x |
| EV/FCF | 3.2x |
| PEG | N/A |
| FCF yield | 568.4% |
Historical Medians
Against its 10-year medians, its P/B is 88.9% below 2.7x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | N/A | 1.6x | N/A |
| P/B | 0.3x | 2.4x | 2.7x |
Valuation History
Over the 3 of the 8 year ends shown that have a P/E, its P/E ranged from 40.4x in 2023 to 206.1x in 2024.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $1.31 | N/A | 0.3x | 1.1x |
| 2024 | $6.08 | 206.1x | 1.0x | 1.2x |
| 2023 | $13.73 | 40.4x | 1.9x | 2.9x |
| 2022 | $12.03 | N/A | 1.6x | 2.8x |
| 2021 | $14.14 | 157.1x | 2.1x | 7.1x |
| 2020 | $6.20 | N/A | 1.4x | 4.0x |
| 2019 | $5.05 | N/A | 1.2x | 3.9x |
| 2018 | $10.07 | N/A | 0.2x | 0.3x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BIOX
What is BIOX's forward P/E ratio?
Bioceres Crop Solutions has a forward P/E ratio of 15.0x.
Is BIOX stock overvalued?
GNG's valuation label for BIOX is Undervalued.
BIOX pages: Overview, Earnings, Financials, Valuation